Investing in Calithera Biosciences, Inc. (CALA)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)2.91Infinity
Intrinsic value (DCF)2.91Infinity
Graham-Dodd Method0.00NaN
Graham Formula0.00NaN

Company description

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.